Loading...
ZimVie Inc.
ZIMV•NASDAQ
Healthcare
Medical - Devices
$18.72
$-0.01(-0.05%)
ZimVie Inc. (ZIMV) Financial Performance & Income Statement Overview
Review ZimVie Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.68%
↓ 1.68%
Operating Income Growth
33.21%
↑ 33.21%
Net Income Growth
93.43%
↑ 93.43%
Operating Cash Flow Growth
-61.84%
↓ 61.84%
Operating Margin
-2.31%
↓ 2.31%
Gross Margin
44.07%
↑ 44.07%
Net Profit Margin
-3.23%
↓ 3.23%
ROE
-3.63%
↓ 3.63%
ROIC
-1.63%
↓ 1.63%
ZimVie Inc. (ZIMV) Income Statement & Financial Overview
Review ZimVie Inc.'s (ZIMV) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $112.00M | $111.52M | $103.22M | $116.81M |
| Cost of Revenue | $0.00 | $38.71M | $41.86M | $49.52M |
| Gross Profit | $0.00 | $66.82M | $61.37M | $67.30M |
| Gross Profit Ratio | $0.00 | $0.60 | $0.59 | $0.58 |
| R&D Expenses | $5.37M | $6.70M | $6.93M | $6.58M |
| SG&A Expenses | $58.98M | $58.56M | $57.31M | $62.38M |
| Operating Expenses | $64.36M | $79.14M | $64.24M | $68.96M |
| Total Costs & Expenses | $0.00 | $117.85M | $106.10M | $118.48M |
| Interest Income | $2.04M | $2.11M | $2.47M | $1.97M |
| Interest Expense | -$4.05M | $4.12M | $4.83M | $5.07M |
| Depreciation & Amortization | $0.00 | $43000.00 | $8.78M | $8.49M |
| EBITDA | $780000.00 | -$9.67M | $9.87M | $6.78M |
| EBITDA Ratio | $0.007 | -$0.09 | $0.10 | $0.06 |
| Operating Income | $780000.00 | -$6.33M | -$3.05M | -$1.67M |
| Operating Income Ratio | $0.007 | -$0.06 | -$0.03 | -$0.01 |
| Other Income/Expenses (Net) | -$331000.00 | $738000.00 | -$688000.00 | -$91000.00 |
| Income Before Tax | $449000.00 | -$5.59M | -$3.74M | -$6.78M |
| Income Before Tax Ratio | $0.004 | -$0.05 | -$0.04 | -$0.06 |
| Income Tax Expense | -$3.07M | $4.08M | -$688000.00 | $2.77M |
| Net Income | $3.52M | -$11.56M | -$2.28M | -$4.01M |
| Net Income Ratio | $0.03 | -$0.10 | -$0.02 | -$0.03 |
| EPS | -$0.09 | -$0.43 | -$0.08 | -$0.15 |
| Diluted EPS | -$0.09 | -$0.43 | -$0.08 | -$0.15 |
| Weighted Avg Shares Outstanding | $0.00 | $27.60M | $27.57M | $27.41M |
| Weighted Avg Shares Outstanding (Diluted) | $0.00 | $27.60M | $27.57M | $27.41M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan